Evidence map›Paper›PMID 31317016›Full record

ArticleAnnals of translational medicine2019

Seronegative atypical anti-glomerular basement membrane crescentic glomerulonephritis.

Sreedhar Adapa, Venu Madhav Konala, Jean Hou, Srikanth Naramala, Nikhil Agrawal, Hemant Dhingra, Wilbert S Aronow

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Atypical Anti-Glomerular Basement Membrane Disease.Kidney international reports · 2023
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Sreedhar AdapaDivision of Nephrology, The Nephrology Group, Fresno, CA, USA.
Venu Madhav KonalaDepartment of Internal Medicine/Division of Medical Oncology, Ashland Bellefonte Cancer Center, Ashland, KY, USA.
Jean HouDepartment of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Srikanth NaramalaDivision of Rheumatology, Adventist Medical Center, Hanford, CA, USA.
Nikhil AgrawalDivision of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Hemant DhingraDepartment of Medicine, St Agnes Medical Center, Fresno, CA, USA.
Wilbert S AronowDivision of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY, USA.
Adventist HealthCare · USAshland Bellefonte Cancer Center · USBeth Israel Deaconess Medical Center · USCedars-Sinai Medical Center · USSaint Agnes Medical Center · USWestchester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 46-year-old female presented with a chief complaint of fatigue and intermittent painless gross hematuria for one month. The patient was fluid overloaded on physical examination and noted to be in acute renal failure with a serum creatinine of 10.8 mg/dL. The patient was emergently started on hemodialysis. Serologies were negative for antinuclear antibody (ANA), anti-neutrophilic cytoplasmic antibody (ANCA), and anti-glomerular basement membrane (anti-GBM) antibody. However, renal biopsy revealed 90% glomerular involvement by temporally heterogeneous crescents ranging from cellular to fibrous. Immunofluorescence studies revealed strong, linear glomerular capillary wall staining for immunoglobulin G (IgG). Although the patient was treated with pulse dose steroids and cyclophosphamide, the patient ultimately developed infectious complications from immunosuppression, and treatment was terminated. This case highlights the atypical presentation of anti-GBM disease diagnosed based on renal biopsy with negative serologies. Although rare, the possibility of atypical anti-GBM antibodies which are not detected by standard commercial assays should be considered in such cases.

Indexed as

Anti-glomerular basement membrane disease (anti-GBM disease)atypical anti-GBM antibodiescrescentic glomerulonephritis

Identifiers

PMID31317016
PMCPMC6603348
OpenAlexW2943671824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.